Markets › United States › NAS › ONC

BeOne Medicines Ltd

NAS:ONCHealthcareNASDAQ:NBInasdaq_composite

$370.17+0.30%At closeAt close · Tue 20 Oct · ≈ AED 1,359.45 · Market cap $40.45B · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	77.1%	86.0%	79.8%	84.5%	84.4%	87.5%	—	—
Operating margin	−536.7%	−122.3%	−126.4%	−49.1%	−14.9%	8.4%	8.4%	+0.0 pts
Net margin	−526.1%	−123.9%	−141.5%	−35.9%	−16.9%	5.4%	5.4%	+0.0 pts
EBITDA margin	−526.4%	−118.4%	−133.8%	−30.0%	−9.5%	11.5%	—	—
Return on equity	−42.0%	−23.8%	−45.7%	−24.9%	−19.4%	6.6%	6.6%	+0.0 pts
Return on assets	−29.0%	−17.1%	−31.4%	−15.2%	−10.9%	3.5%	3.5%	+0.0 pts
Return on capital employed	−36.6%	−20.7%	−36.4%	−30.2%	−15.3%	7.0%	—	—
Debt / equity	0.1×	0.1×	0.1×	0.3×	0.3×	0.5×	0.5×	+0.0%
Debt / assets	10.0%	8.1%	9.4%	16.0%	18.2%	24.4%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	7.7×	—	—
Current ratio	4.6×	4.8×	3.5×	2.3×	1.8×	3.4×	3.4×	+0.0%
Quick ratio	4.5×	4.6×	3.4×	2.1×	1.6×	3.1×	—	—
Cash ratio	1.3×	2.7×	2.6×	1.8×	1.2×	2.5×	2.5×	+0.0%
Asset turnover	0.1×	0.1×	0.2×	0.4×	0.6×	0.7×	—	—
Inventory turnover	0.8×	0.7×	1.0×	0.9×	1.2×	1.1×	—	—
Receivables turnover	5.1×	2.4×	7.1×	6.2×	5.4×	6.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—